心瑋醫療-B：年度報告 2023

Futu NewsApr 17 04:44 ET · Announcements

Interpretation of Xinwei Medical-B (6609.HK) Annual Report: Innovation and Globalization, Therapeutic Products Save Development Potential

The concept of “new quality productivity” was emphasized many times during the two sessions. In particular, the medical device industry, the high-end medical device sector, which is driven by scientific and technological innovation as the core driving force, is undoubtedly also moving towards a rapid development path as an important indicator for measuring the country's level of high-tech development.

Gelonghui FinanceApr 1 20:48 ET

Xinwei Medical-B (06609.HK) announced annual results: business focus on driving product structure transformation, gross margin rose to 70.5%, losses narrowed, and major neurointerventional treatment devices are about to be launched

Gelonghui March 28 | Xinwei Medical-B (06609.HK) announced its annual results. For the year ended December 31, 2023, the company's revenue increased to RMB 232.3 million, an increase of 26.9% year on year, and loss before tax narrowed to RMB 102.9 million, a year-on-year decrease of 48.9%. With the expansion of business scale and the effects of cost control and efficiency measures, the company's gross margin increased 2.6 percentage points to 70.5%, and the share of sales and distribution expenses and administrative expenses decreased to 66.2% (2022:91.8%). In 2023, in order to adapt to a rapidly changing city

Gelonghui FinanceMar 28 06:13 ET

Xinwei Medical-B (06609) announced 2023 annual results with revenue of 232 million yuan, an increase of 26.9% year-on-year

Xinwei Medical-B (06609) announced its annual results for the year ended December 31, 2023. The group achieved revenue of 232 million yuan (RMB, same below) during the period, an increase of 26.9%; the parent company's owners should have accounted for a loss of 94.012 million yuan, a year-on-year decrease of 53.08%; and a basic loss of 2.47 yuan per share.

Zhitong FinanceMar 28 05:18 ET

HEARTCARE-B: ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED DECEMBER 31, 2023

Futu NewsMar 28 04:44 ET · Announcements

Xinwei Medical-B (06609.HK) plans to hold a board meeting on March 28 to approve the annual results

Gelonghui, March 18, 丨 Xinwei Medical-B (06609.HK) announced that the company will hold a board meeting on March 28, 2024 (Thursday) to review and approve the annual results and announcements of the company and its subsidiaries for the year ended 31 December 2023, consider recommending payment of a final dividend (if any), and handle any other business.

Gelonghui FinanceMar 18 05:02 ET